Sections
- 1 Short title
- 2 Interpretation
- PART II: CLINICAL RESEARCH REGULATORY COUNCIL
- 3 Clinical Research Regulatory Council
- 4 Functions and powers of Council
- 5 Meetings of Council
- 6 Secretary and other officers of Council
- PART III: ETHICS COMMITTEE
- 7 Ethics Committee
- 8 Functions of Ethics Committee
- PART IV: PHARMACOVIGILANCE COMMITTEE
- 9 Pharmacovigilance Committee
- 10 Functions of Pharmacovigilance Committee
- PART IVA: PUBLIC CLINICAL TRIAL UNIT AND NATIONAL CLINICAL TRIAL NETWORK
- 10A Public Clinical Trial Unit inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- 10B Recruitment of participants receiving care within inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- 10C Collaboration with Public Clinical Trial Unit inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- 10D National Cancer Clinical Trials Programme inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- PART V: TRIAL LICENCE
- 11 Trial licence
- PART IVA: PUBLIC CLINICAL TRIAL UNIT AND NATIONAL CLINICAL TRIAL NETWORK
- 11 Trial licence inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- PART V: TRIAL LICENCE
- 12 Application for trial licence
- 13 Grant of application
- PART IVA: PUBLIC CLINICAL TRIAL UNIT AND NATIONAL CLINICAL TRIAL NETWORK
- 13A Expedited review inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- PART V: TRIAL LICENCE
- 14 Refusal of application
- 15 Amendment of trial licence
- 16 Suspension or cancellation of trial licence
- PART VA: REGISTRATION CERTIFICATE
- 16A Registration certificate inserted by Finance (Miscellaneous Provisions) Act 2019
- 16B Grant of application inserted by Finance (Miscellaneous Provisions) Act 2019
- 16C Refusal of application inserted by Finance (Miscellaneous Provisions) Act 2019
- 16D Suspension or cancellation of registration certificate inserted by Finance (Miscellaneous Provisions) Act 2019
- PART VI: CONDUCT OF CLINICAL TRIALS
- 17 Good clinical practice
- 18 The sponsor
- 19 The investigator
- PART IVA: PUBLIC CLINICAL TRIAL UNIT AND NATIONAL CLINICAL TRIAL NETWORK
- 19A Accredited principal investigators inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- PART VI: CONDUCT OF CLINICAL TRIALS
- 20 Protection of subjects
- 21 Emergency measures
- 22 Strict liability of sponsor
- 23 Trial master file and archiving
- 24 Progress and completion of clinical trial reports
- 25 Completion and discontinuance of clinical trial
- PART VII: INSPECTIONS
- 26 Verification of compliance
- PART VIII: PHARMACOVIGILANCE
- 27 Record of adverse event or reaction
- 28 Notification of serious adverse event or reaction
- PART IX: REGISTER OF CLINICAL TRIALS
- 29 Register of clinical trials
- 29A Register of contract research organisations inserted by Finance (Miscellaneous Provisions) Act 2019
- PART X: OFFENCES
- 30 Offences
- PART XI: MISCELLANEOUS PROVISIONS
- 31 Annual report
- 32 Powers of Minister
- 33 Disclosure of interest
- 34 Protection from liability
- PART IVA: PUBLIC CLINICAL TRIAL UNIT AND NATIONAL CLINICAL TRIAL NETWORK
- 34 Protection from liability inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- 34A Exemption from fees inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026
- PART XI: MISCELLANEOUS PROVISIONS
- 35 Regulations
consolidated text (as at 2017, amended since). juris shows the text as it was consolidated; it does not confirm that this is the law in force today.
Later amending instruments held: Finance (Miscellaneous Provisions) Act 2019 (Act No 13 of 2019), Finance (Miscellaneous Provisions) Act 2023 (Act No 12 of 2023), Finance (Miscellaneous Provisions) Act 2024 (Act No. 11 of 2024), Economic and Financial Measures (Miscellaneous Provisions) Act 2026 (Act No 13 of 2026).